The content is available as a PDF (224.8 KB).
. 2020 May 28:hcaa182. doi: 10.1093/qjmed/hcaa182
Challenges of community point-of-care antibody testing for COVID-19 herd-immunity in Japan
Morihito Takita
h1,✉, Tomoko Matsumura
h1, Kana Yamamoto
h1,h2,h3, Erika Yamashita
h2, Kazutaka Hosoda
h4, Tamae Hamaki
h2, Eiji Kusumi
h1,h2
Morihito Takita, MD, PhD
h1Department of Internal Medicine, Navitas Clinic Tachikawa, 3-1-1 Shibasaki 4th floor of Ecute Tachikawa Bldg, Tachikawa, Tokyo, Japan
Find articles by Morihito Takita
Tomoko Matsumura, MD, PhD
h1Department of Internal Medicine, Navitas Clinic Tachikawa, 3-1-1 Shibasaki 4th floor of Ecute Tachikawa Bldg, Tachikawa, Tokyo, Japan
Find articles by Tomoko Matsumura
Kana Yamamoto, MD
h1Department of Internal Medicine, Navitas Clinic Tachikawa, 3-1-1 Shibasaki 4th floor of Ecute Tachikawa Bldg, Tachikawa, Tokyo, Japan
h2Department of Internal Medicine, Navitas Clinic Shinjuku, 4-1-6 Shinjuku 7th floor of Newoman Bldg, Shinjuku, Tokyo, Japan
h3Department of Reproductive, Developmental and Aging Sciences, Graduate School of Medicine, University of Tokyo, 4-6-1 Shirokanedai, Minato, Tokyo, Japan
Find articles by Kana Yamamoto
Erika Yamashita
h2Department of Internal Medicine, Navitas Clinic Shinjuku, 4-1-6 Shinjuku 7th floor of Newoman Bldg, Shinjuku, Tokyo, Japan
Find articles by Erika Yamashita
Kazutaka Hosoda, MD
h4Department of Pediatrics, Navitas Clinic Tachikawa, Tachikawa, 3-1-1 Shibasaki 4th floor of Ecute Tachikawa Bldg, Tachikawa, Tokyo, Japan
Find articles by Kazutaka Hosoda
Tamae Hamaki, MD
h2Department of Internal Medicine, Navitas Clinic Shinjuku, 4-1-6 Shinjuku 7th floor of Newoman Bldg, Shinjuku, Tokyo, Japan
Find articles by Tamae Hamaki
Eiji Kusumi
h1Department of Internal Medicine, Navitas Clinic Tachikawa, 3-1-1 Shibasaki 4th floor of Ecute Tachikawa Bldg, Tachikawa, Tokyo, Japan
h2Department of Internal Medicine, Navitas Clinic Shinjuku, 4-1-6 Shinjuku 7th floor of Newoman Bldg, Shinjuku, Tokyo, Japan
Find articles by Eiji Kusumi
h1Department of Internal Medicine, Navitas Clinic Tachikawa, 3-1-1 Shibasaki 4th floor of Ecute Tachikawa Bldg, Tachikawa, Tokyo, Japan
h2Department of Internal Medicine, Navitas Clinic Shinjuku, 4-1-6 Shinjuku 7th floor of Newoman Bldg, Shinjuku, Tokyo, Japan
h3Department of Reproductive, Developmental and Aging Sciences, Graduate School of Medicine, University of Tokyo, 4-6-1 Shirokanedai, Minato, Tokyo, Japan
h4Department of Pediatrics, Navitas Clinic Tachikawa, Tachikawa, 3-1-1 Shibasaki 4th floor of Ecute Tachikawa Bldg, Tachikawa, Tokyo, Japan
✉
Corresponding Author: Morihito Takita, MD, PhD, Department of Internal Medicine, Navitas Clinic Tachikawa, Address: 3-1-1 Shibasaki, Ecute Tachikawa 4th floor, Tachikawa, Tokyo, 190-0023, Japan, Phone: +81-42-521-5334, Fax: +81-42-521-5329, Email: takita-ygc@umin.ac.jp
Received 2020 May 17; Revised 2020 May 19; Accepted 2020 May 22.
Keywords: COVID-19, antibody test, point-of-care testing, epidemiology
© The Author(s) 2020. Published by Oxford University Press on behalf of the Association of Physicians. All rights reserved. For Permissions, please email: journals.permissions@oup.com
This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)
This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.
PMCID: PMC7313848 PMID: 32467977